3D visualisation of hepatitis B vaccine in the oral delivery vehicle SBA-15-Reference-Cited by-同舟云学术

3D visualisation of hepatitis B vaccine in the oral delivery vehicle SBA-15

Published:2019-04-15 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Rasmussen Martin K.,Kardjilov Nikolay,Oliveira Cristiano L. P.,Watts Benjamin^ORCID,Villanova Julie,Botosso Viviane Fongaro,Sant’Anna Osvaldo A.,Fantini Marcia C. A.^ORCID,Bordallo Heloisa N.^ORCID

Funder

Ministry of Science, Innovation and Higher Education | Styrelsen for Forskning og Innovation

Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico

Bundesministerium für Bildung und Forschung

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-42645-5.pdf

Reference41 articles.

1. Petrovsky, N. Comparative safety of vaccine adjuvants: a summary of current evidence and future needs. Drug Safety 38, 1059–1074 (2015).

2. Davitt, C. J. H. Delivery strategies to enhance oral vaccination against enteric infections. Advanced Drug Delivery Reviews 91, 52–69 (2015).

3. Levine, M. M. Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC Biology 8, 129 (2010).

4. Yuki, Y. et al. Mucosal vaccines: novel advances in technology and delivery. Expert Review of Vaccines 8, 1083–1097 (2009).

5. Holmgren, J. et al. Mucosal immunity and vaccines. Nature Medicine 11, 45 (2005).

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Ac2-26 Mesoporous Microparticle System as a Potential Therapeutic Agent for Inflammatory Bowel Diseases;International Journal of Nanomedicine;2024-04

2. Ordered mesoporous silicas for potential applications in solid vaccine formulations;Vaccine;2024-01

3. Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines;Vaccines;2023-06-29

4. Use of Nanostructured Silica SBA-15 as an Oral Vaccine Adjuvant to Control Mycoplasma hyopneumoniae in Swine Production;International Journal of Molecular Sciences;2023-04-01

5. Nanoparticles as a Delivery System of Antigens for the Development of an Effective Vaccine against Toxoplasma gondii;Vaccines;2023-03-25